Evidence map›Paper›PMID 34641383›Full record

ArticleMolecules (Basel, Switzerland)2021

Probing the Suitability of Different Ca

Alexander Zlobin, Igor Diankin, Sergey Pushkarev, Andrey Golovin

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Alexander ZlobinFaculty of Bioengineering, Lomonosov Moscow State University, 119234 Moscow, Russia.
Igor DiankinFaculty of Bioengineering, Lomonosov Moscow State University, 119234 Moscow, Russia.
Sergey PushkarevFaculty of Bioengineering, Lomonosov Moscow State University, 119234 Moscow, Russia.
Andrey GolovinFaculty of Bioengineering, Lomonosov Moscow State University, 119234 Moscow, Russia.ORCID 0000-0002-8908-4268

Funding

Russian Foundation for Basic Research 19-34-51043Russian Science Foundation 21-74-20113
6 · The paper itself

Abstract

Organophosphate hydrolases are promising as potential biotherapeutic agents to treat poisoning with pesticides or nerve gases. However, these enzymes often need to be further engineered in order to become useful in practice. One example of such enhancement is the alteration of enantioselectivity of diisopropyl fluorophosphatase (DFPase). Molecular modeling techniques offer a unique opportunity to address this task rationally by providing a physical description of the substrate-binding process. However, DFPase is a metalloenzyme, and correct modeling of metal cations is a challenging task generally coming with a tradeoff between simulation speed and accuracy. Here, we probe several molecular mechanical parameter combinations for their ability to empower long simulations needed to achieve a quantitative description of substrate binding. We demonstrate that a combination of the Amber19sb force field with the recently developed 12-6 Ca

Indexed as

Molecular Dynamics SimulationCalciumCatalytic DomainModels, MolecularPhosphoric Triester HydrolasesProtein ConformationCalciumdiisopropyl-fluorophosphatasePhosphoric Triester HydrolasesDFPasediisopropyl fluorophosphataseforce fieldmetadynamicsmolecular dynamicsQM/MMsubstrate binding

Identifiers

PMID34641383
PMCPMC8510429

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.